華潤有巢REIT提前結束公眾投資者募集 將進行比例配售金
華潤置地(01109.HK)與中信証券(06030.HK)、華夏基金合作,由有巢住房租賃(深圳)作為發起人發起的華潤有巢保障性租賃住房封閉式基礎設施證券投資基金(華潤有巢REIT)公布,原訂於本周一至周二(14日至15日)進行公眾投資者募集,但由於首日累計有效的公眾投資者認購規模已超出初始募集規模上限,因此華夏基金決定提前結束公眾投資者募集期。
基金管理人將按照基金份額發售公告中的相關約定,對公眾投資者有效認購申請採用「全程比例配售」的原則予以確認。至於基金戰略投資者及網下投資者的募集期限保持不變,仍為14日至15日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.